FY2025 · ended Dec 31, 2025 · Revenue $1.39B, +10.7% YoY · Filed Feb 25, 2026
LivaNova PLC (LIVN) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.4 billion and a net loss of $242.5 million. Free cash flow was $173.3 million. As of Sep 30, 2026 it held $580.3 million in cash and investments and $353.4 million in total debt.
Revenue (TTM)
$1.51B
+11.7% vs year-ago TTM
Net income (TTM)
$196.06M
+190.1% vs year-ago TTM
Operating cash flow (TTM)
$237.86M
-5.1% vs year-ago TTM
Free cash flow (TTM)
$129.02M
-32.6% vs year-ago TTM
EPS (TTM)
$3.51
+188.0% vs year-ago TTM
Dividend per share
None
Shares outstanding
54.69M
+0.6% vs prior year
Net cash
$226.90M
as of Sep 30, 2026
Operating margin
10.7%
FY 2026
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- LIVN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Gloucester
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1639691
- Former names
- Sand Holdco Plc (until Jun 12, 2015)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.3B | $1.2B | $1.0B | $1.0B |
| Operating income | $199.4M | $129.1M | -$68.5M | -$76.8M | -$784,000 |
| Net income | -$242.5M | $63.2M | $17.5M | -$86.2M | -$135.8M |
| Diluted EPS | -$4.45 | $1.16 | $0.32 | -$1.61 | -$2.68 |
| Operating cash flow | $254.3M | $183.0M | $74.9M | $69.9M | $102.5M |
| Free cash flow | $173.3M | $135.9M | $39.9M | $43.4M | $77.1M |
| Total assets | $2.6B | $2.5B | $2.4B | $2.3B | $2.2B |
| Total liabilities | $1.4B | $1.2B | $1.2B | $1.1B | $906.3M |
| Stockholders' equity | $1.2B | $1.3B | $1.3B | $1.2B | $1.3B |
| Cash and investments | $655.8M | $428.9M | $266.5M | $214.2M | $208.0M |
| Total debt | $433.2M | $676.1M | $639.8M | $577.9M | $284.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 10, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
All 954 LivaNova PLC SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.